Barclays’s Cubist Pharmaceuticals CBST Stock Holding History
Bought
Maintained
Sold
Barclays's CBST Position: Q1 2015 in Review
Barclays sold out of Cubist Pharmaceuticals (CBST) in Q1 2015, closing a stake of 516,050 shares — an estimated $51.6M sold.
Barclays first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $62.1M in Q4 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.
- Barclays reported no remaining Cubist Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- Barclays sold 516,050 Cubist Pharmaceuticals shares in Q1 2015, an estimated $51.6M.
- Barclays first reported a position in Cubist Pharmaceuticals in Q2 2013 and held it in 7 quarters.
- Barclays's Cubist Pharmaceuticals position peaked at $62.1M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Cubist Pharmaceuticals as of Q1 2015.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.